GAITHERSBURG, Md., July 29 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC - News) announced today that it has received a Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the company’s malaria vaccine program.
